In the News

Welcome to DUSA » In the News

DUSA in the News

Browse DUSA’s news and features to access a comprehensive collection of company press materials and public engagements. Interested media can also obtain background materials and high resolution images within the DUSA Media Kit.


DUSA Pharmaceuticals Ranked 19th in The Boston Globe "Globe 100"

A Message from Robert Doman
President & CEO
May 2012

As some of you may have seen in the news over the weekend DUSA Pharmaceuticals was ranked 19th in The Boston Globe 100, the annual Globe list of the top performing public companies in Massachusetts.  The annual ranking of companies appeared in a magazine published in The Boston Sunday Globe on Sunday, May 20th and can be seen at In order to qualify for the Globe 100, a company must have been public for the entire 2011 calendar year and have reported a positive net income for both 2010 and 2011.

The Globe 100 ranks the best-performing companies by how well they increased sales, profits and returns for shareholders during 2011.  The companies are ranked on four criteria:

- Return on average equity, a measure of how effectively shareholder money is employed
- One -year percentage change in revenue
- One-year percentage change in profit margin
- 2011 revenue

This is the first time DUSA has received this recognition from the Globe and we are excited to share the achievement of another significant milestone for the company with all of you. To all of the friends of DUSA we want to take a moment to say thank you for your continued support.  Congratulations to all our employees whose efforts and commitment to the company over the years have made this possible. 

Best regards,

Bob Doman


Recent Press Releases

December 20, 2012
Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA

December 5, 2012
Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer

November 8, 2012
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.

November 5, 2012
DUSA Pharmaceuticals, Inc. to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

September 13, 2012
DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study